Newron Pharmaceuticals SpA (NWPHF)
OTHER OTC:NWPHF
Holding NWPHF?
Track your performance easily

Newron Pharmaceuticals SpA (NWPHF) Technical Analysis

8 Followers

Summary of all the Indicators

Overall Consensus
Buy
8Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Neutral
1Bullish
1Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Newron Pharmaceuticals SpA’s (NWPHF) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Newron Pharmaceuticals SpA is a Sell.
Newron Pharmaceuticals SpA’s (NWPHF) 20-Day exponential moving average is 9.36, while Newron Pharmaceuticals SpA’s (NWPHF) share price is $9.36, making it a Buy.
Newron Pharmaceuticals SpA’s (NWPHF) 50-Day exponential moving average is 9.48, while Newron Pharmaceuticals SpA’s (NWPHF) share price is $9.36, making it a Sell.

Newron Pharmaceuticals SpA (NWPHF) Pivot Points

Nov 10, 2024, 03:45 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.36
9.36
9.36
9.36
9.36
9.36
9.36
Fibonacci
9.36
9.36
9.36
9.36
9.36
9.36
9.36
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Newron Pharmaceuticals SpA (NWPHF) Moving Averages

Nov 10, 2024, 03:45 AM
Period
Simple
Exponential
MA5
9.36Buy
9.36Buy
MA10
9.36Sell
9.36Buy
MA20
9.36Buy
9.36Buy
MA50
9.32Buy
9.48Sell
MA100
10.11Sell
9.64Sell
MA200
9.72Sell
9.15Buy
Newron Pharmaceuticals SpA’s (NWPHF) 10-Day exponential moving average is 9.36, while Newron Pharmaceuticals SpA’s (NWPHF) share price is $9.36, making it a Buy.
Newron Pharmaceuticals SpA’s (NWPHF) 100-Day exponential moving average is 9.64, while Newron Pharmaceuticals SpA’s (NWPHF) share price is $9.36, making it a Sell.
Newron Pharmaceuticals SpA’s (NWPHF) stock price is $9.36 and Newron Pharmaceuticals SpA’s (NWPHF) 50-day simple moving average is 9.32, creating a Buy signal.
Newron Pharmaceuticals SpA’s (NWPHF) stock price is $9.36 and Newron Pharmaceuticals SpA’s (NWPHF) 100-day simple moving average is 10.11, creating a Sell signal.
Newron Pharmaceuticals SpA’s (NWPHF) stock price is $9.36 and Newron Pharmaceuticals SpA’s (NWPHF) 200-day simple moving average is 9.72, creating a Sell signal.

Newron Pharmaceuticals SpA (NWPHF) Technical Indicators

Nov 10, 2024, 03:45 AM
Name
Value
Implied Action
RSI (14)
37.60
Neutral
STOCH (9,6)
0.00
-
STOCHRSI (14)
0.00
-
MACD (12,26)
>-0.01
Sell
CCI (14)
0.00
-
ATR (14)
<0.01
-
ROC
0.00
-
Bull/Bear Power (13)
<0.01
Buy
Newron Pharmaceuticals SpA’s (NWPHF) Relative Strength Index (RSI) is 37.60, creating a Neutral signal.

FAQ

Is NWPHF a Buy, Hold, or Sell?
Based on NWPHF’s technical indicators, NWPHF is a Buy.
    What is NWPHF’s RSI (14)?
    NWPHF’s RSI (14) is 37.60, which suggests NWPHF is a Neutral.
      What is NWPHF’s MACD?
      NWPHF’s MACD is >-0.01, which suggests NWPHF is a Sell.
        What is NWPHF’s 5-day moving average?
        NWPHF’s 5-day moving average is 9.36, which suggests NWPHF is a Buy.
          What is NWPHF’s 20-day moving average?
          NWPHF 20-day moving average is 9.36, which suggests NWPHF is a Buy.
            What is NWPHF’s 50-day moving average?
            NWPHF’s 50-day moving average is 9.32, which suggests NWPHF is a Buy.
              What is NWPHF’s 200-day moving average?
              NWPHF’s 200-day moving average is 9.72, which suggests NWPHF is a Sell.
                What is NWPHF’s Williams % R (14)?
                Currently, no data Available
                What is NWPHF’s CCI (14)?
                Currently, no data Available
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis